313 related articles for article (PubMed ID: 23140648)
41. Clozapine and myocarditis: a case series from the New Zealand Intensive Medicines Monitoring Programme.
Hill GR; Harrison-Woolrych M
N Z Med J; 2008 Oct; 121(1283):68-75. PubMed ID: 18841187
[TBL] [Abstract][Full Text] [Related]
42. [Clozapine and resistant schizophrenia].
Pere JJ; Chaumet-Riffaud D
Encephale; 1990; 16(2):143-5. PubMed ID: 1972053
[TBL] [Abstract][Full Text] [Related]
43. Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: a case report.
Barnas C; Zwierzina H; Hummer M; Sperner-Unterweger B; Stern A; Fleischhacker WW
J Clin Psychiatry; 1992 Jul; 53(7):245-7. PubMed ID: 1639744
[TBL] [Abstract][Full Text] [Related]
44. [Risk minimization evolution of agranulocytosis caused by the administration of pharmaceutical products containing Clozapine in Argentina].
Bergman M; Bignone I; Bisio A; Bologna V; Sabatini A
Vertex; 2011; 22(96):94-7. PubMed ID: 21977603
[TBL] [Abstract][Full Text] [Related]
45. Incidence and risk factors for clozapine-induced myocarditis and cardiomyopathy at a regional mental health service in Australia.
Youssef DL; Narayanan P; Gill N
Australas Psychiatry; 2016 Apr; 24(2):176-80. PubMed ID: 26400457
[TBL] [Abstract][Full Text] [Related]
46. [The atypical neuroleptic clozapine (Leponex)--current knowledge and recent clinical aspects].
Klimke A; Klieser E
Fortschr Neurol Psychiatr; 1995 May; 63(5):173-93. PubMed ID: 7782019
[TBL] [Abstract][Full Text] [Related]
47. Impact of complete blood count sampling time change on white blood cell and absolute neutrophil count values in clozapine recipients.
McKee JR; Wall T; Owensby J
Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):26-32. PubMed ID: 21459736
[TBL] [Abstract][Full Text] [Related]
48. Agranulocytosis monitoring with Clozapine patients: to follow guidelines or to attempt therapeutic controversies?
Chandrasekaran PK
Singapore Med J; 2008 Feb; 49(2):96-9. PubMed ID: 18301833
[TBL] [Abstract][Full Text] [Related]
49. Clozapine-induced agranulocytosis: a situation report up to August 1976.
Anderman B; Griffith RW
Eur J Clin Pharmacol; 1977 Mar; 11(3):199-201. PubMed ID: 852497
[TBL] [Abstract][Full Text] [Related]
50. Clozapine-induced agranulocytosis and leukopenia: Incidence, associated factors, and rate of hematologic adverse-effects monitoring in psychiatric out-patient services in Thailand.
Tunsirimas N; Pariwatcharakul P; Choovanichvong S; Ratta-Apha W
Asian J Psychiatr; 2019 Mar; 41():13-16. PubMed ID: 30856469
[TBL] [Abstract][Full Text] [Related]
51. Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia.
Rajagopal G; Graham JG; Haut FF
J Intellect Disabil Res; 2007 Jan; 51(Pt 1):82-5. PubMed ID: 17181606
[TBL] [Abstract][Full Text] [Related]
52. [Monitoring of side effects induced by psychotropic drugs].
Kusumi I
Seishin Shinkeigaku Zasshi; 2014; 116(2):116-22. PubMed ID: 24712271
[TBL] [Abstract][Full Text] [Related]
53. [A case of neutropenia and agranulocytosis induced by clozapine. The importance of a drug surveillance program for their early detection].
Alfaro J; Berdichevsky E; Conte G; Tellez C
Rev Med Chil; 1994 Jun; 122(6):694-8. PubMed ID: 7732216
[TBL] [Abstract][Full Text] [Related]
54. Clozapine and Gastrointestinal Hypomotility.
Cohen D
CNS Drugs; 2017 Dec; 31(12):1083-1091. PubMed ID: 29230675
[TBL] [Abstract][Full Text] [Related]
55. Testing the hypothesis that selenium deficiency is a risk factor for clozapine-induced agranulocytosis in rats.
Ip J; Uetrecht JP
Chem Res Toxicol; 2008 Apr; 21(4):874-8. PubMed ID: 18380444
[TBL] [Abstract][Full Text] [Related]
56. Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine.
Wehmeier PM; Heiser P; Remschmidt H
J Clin Pharm Ther; 2005 Feb; 30(1):91-6. PubMed ID: 15659009
[TBL] [Abstract][Full Text] [Related]
57. Clozapine: is now the time for more clinicians to adopt this orphan?
Stahl SM
CNS Spectr; 2014 Aug; 19(4):279-81. PubMed ID: 25267329
[TBL] [Abstract][Full Text] [Related]
58. [Agranulocytosis in the course of clozapine treatment].
Załuska M; Gajewska J
Psychiatr Pol; 1995; 29(1):67-77. PubMed ID: 7878156
[TBL] [Abstract][Full Text] [Related]
59. [Incidence and fatality of the acute and chronic complications of diabetes mellitus in Mexico].
Escobedo-de la Pena J; Rico-Verdín B
Salud Publica Mex; 1996; 38(4):236-42. PubMed ID: 8966628
[TBL] [Abstract][Full Text] [Related]
60. Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic review.
Knoph KN; Morgan RJ; Palmer BA; Schak KM; Owen AC; Leloux MR; Patel M; Leung JG
Schizophr Res; 2018 Sep; 199():17-30. PubMed ID: 29548760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
